Today, the US Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) announced a new prize competition from the Kidney Innovation Accelerator (KidneyX) that seeks to further the development of a fully functional bioartificial kidney. Phase 2 of the Artificial Kidney Prize competition invites submissions focused on developing prototype bioartificial … Read more
Plesna Village, Lesser Poland Province (source: Zygmunt Put, wikimedia/creative commons) Poland launches second phase of geothermal support program Polska Geotermia Plus supporting two shallower depth geothermal projects. The Polish National Fund for Environmental Protection and Water Management (NFOSiGW) will transfer up to PLN 6 million in subsidies to two resorts in the Lesser Poland Province … Read more
Financing led by a16z and Deerfield Management with participation from Droia Ventures, GV, The Mark Foundation for Cancer Research and the Berkeley Catalyst Fund Exclusive license from academic-industry collaboration with UC Berkeley Professor Daniel Nomura for proprietary DUBTAC platform for targeted protein stabilization SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Vicinitas Therapeutics, a biotechnology company advancing a … Read more
The US Department of Energy’s Princeton Plasma Physics Laboratory (PPPL) moved forward with plans to build the Princeton Plasma Innovation Center (PPIC), a new state-of-the-art office and laboratory building and the first new building on campus in 50 years . The project kicked off during a meeting with architects on July 8. Credit: Photo by … Read more
Replay, a genome writing company reprogramming biology by writing and delivering big DNA, has launched with $55 million in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay, which is based in San Diego, Cal., and London, UK, … Read more
Replay Bio Replay Launchs with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA KKR and OMX Ventures lead $55 million seed funding round Replay’s genomic medicine toolkit encompassex a portfolio of disruptive platform technologies to inheritede and deliver big DNA, including a high payload capacity HSV delivery platform, a hypoimmunogenic cell … Read more
Replay Launchs with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA KKR and OMX Ventures lead $55 million seed funding round Replay’s genomic medicine toolkit encompassex a portfolio of disruptive platform technologies to inheritede and deliver big DNA, including a high payload capacity HSV delivery platform, a hypoimmunogenic cell therapy platform, … Read more
eureKARE, a company focused on financing and building next generation biotech companies in the fields of synthetic biology, has launched its first synthetic biology studio in Belgium. In conjunction with this, eureKARE has appointed Georges Rawadi as chief of biotech studio development. eureKARE said its thematic synthetic biology studio model is a novel, flexible approach … Read more
eureKARE launches synthetic biology studio network with inaugural bmemedical studio in Belgium Georges Rawadi appointed eureKARE‘s Chief of Biotech Studio Development LuxembourgBelgium, and Paris, France – 19 July 2022: eureKARE (“the Company”), a pioneering company focused on financing and building next generation biotechnology companies in the disruptive fields of synthetic biology, today announces the launch … Read more
WASHINGTON, DC – The Biden-Harris Administration, through the US Department of Energy (DOE), today issued Notices of Intent to fund two programs that will advance carbon capture demonstration projects and expand regional pipeline networks to transport carbon dioxide (CO2) for permanent geologic storage or for conversion into valued end uses, such as construction materials. The … Read more